ImmuneBridge
PrivateLast Round
Seed
Mar 23, 2026
Total Funding Raised
$19.7M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
ImmuneBridge is a biotechnology company developing allogeneic cellular immunotherapies that enhance the body's healing capabilities by expanding cord blood-derived immune stem cells to create a reliable and versatile source for cancer treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmuneBridge Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
ImmuneBridge Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 23, 2026 | ||||
| Seed | Apr 10, 2023 |
ImmuneBridge Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LongGame Ventures | Seed |
| NFX | Seed |
| One Way Ventures | Seed |
| Gaingels | Seed |
| M Ventures | Seed |
| T.Rx Capital | Seed |
| Healthspan Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 24, 2026
Dr. Rui Tostoes appointed as new CTO.
- Mar 24, 2026
Raised $8 million in a seed funding round.
ImmuneBridge Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ImmuneBridge's valuation, stock price, and market status.